Progesterone lipid nanoparticles: Scaling up and in vivo human study
- 1 October 2017
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 119, 437-446
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled studyFertility and Sterility, 2014
- High melting lipid based approach for drug delivery: Solid lipid nanoparticlesMaterials Science and Engineering: C, 2013
- Preparation and characterization of chloroaluminum phthalocyanine-loaded solid lipid nanoparticles by thermal analysis and powder X-ray diffraction techniquesJournal of Thermal Analysis and Calorimetry, 2011
- Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug DeliveryAAPS PharmSciTech, 2010
- Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical DeliveryAAPS PharmSciTech, 2009
- Diazepam-Loaded Solid Lipid Nanoparticles: Design and CharacterizationAAPS PharmSciTech, 2009
- Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopyJournal of Controlled Release, 2004
- Production of solid lipid nanoparticles (SLN): scaling up feasibilitiesJournal of Microencapsulation, 2002
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipidsInternational Journal of Pharmaceutics, 2000